Allred Capital Management’s AstraZeneca AZN Stock Holding History

Allred Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,469	Closed	-$204K	–	160
2023 Q1	$204K	Sell	1,469 -224	-13%	-$30.1K	0.11%	150
2022 Q4	$230K	Buy	+1,693	New	+$212K	0.13%	140
2021 Q2	–	Sell	-389	Closed	-$38.7K	–	236
2021 Q1	$38.7K	Buy	+389	New	+$39.1K	0.02%	432
2020 Q1	–	Sell	-429	Closed	-$42.7K	–	185
2019 Q4	$42.7K	Buy	+429	New	+$40.4K	0.02%	358

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Allred Capital Management's AZN Position: Q2 2023 in Review

Allred Capital Management sold out of AstraZeneca (AZN) in Q2 2023, closing a stake of 1,469 shares — an estimated $204K sold.

Allred Capital Management first reported a position in AZN in Q4 2019 and held it in 4 quarters. The position peaked at $230K in Q4 2022. 1,090 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

Allred Capital Management reported no remaining AstraZeneca position as of Q2 2023 after selling out during the quarter.
Allred Capital Management sold 1,469 AstraZeneca shares in Q2 2023, an estimated $204K.
Allred Capital Management first reported a position in AstraZeneca in Q4 2019 and held it in 4 quarters.
Allred Capital Management's AstraZeneca position peaked at $230K in Q4 2022.
1,090 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on Allred Capital Management's 13F filing for Q2 2023, filed 20 Jul 2023.